Perrigo Sold for $1.55 Billion

ALLEGAN, Mich. - A $1.55 billion is in place for Perrigo to sell off its generic prescription drug business.

The Allegan-based company announced on Monday the deal with Altaris Capital Partners, LLC. The new company will take on more than $50 million in payments for research, development and buyer obligations.

Read the full story on WOOD TV.


Sponsored Content

Sponsored Content